カテゴリ： 世界, 医療/バイオ, QYResearch

グリコピロレート錠の世界市場2023年：0.5mg、1mg、2mg

■ 英語タイトル：Global Glycopyrrolate Tablets Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8777）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8777
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：106
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[グリコピロレート錠の世界市場2023年：0.5mg、1mg、2mg]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はグリコピロレート錠のグローバル市場について調査・分析し、世界のグリコピロレート錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（0.5mg、1mg、2mg）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Rising Pharmaceuticals、Kinedexe UK、Intas Pharmaceutical、Aurobindo Pharma USA、Edenbridge Pharmaceuticals、Heritage Pharmaceuticals、Ranbaxy Pharmaceuticals、Sciele Pharma、Boca Pharmacal、Solco Healthcare、Natco Pharma、Dr. Reddy’s Laboratories、Dongting Pharmaceutical、Alembic Labs、Leading Pharma、LGM Pharma Solutions、Nexgen Pharma、Par Pharmaceuticalなどが含まれています。グリコピロレート錠のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、グリコピロレート錠市場規模を算出する際に考慮しました。

・グリコピロレート錠市場の概要
- 製品の定義
- グリコピロレート錠の種類別セグメント
- 世界のグリコピロレート錠市場規模：タイプ別分析（0.5mg、1mg、2mg）
- グリコピロレート錠の用途別セグメント
- 世界のグリコピロレート錠市場規模：用途別分析（病院、クリニック、その他）
- 世界のグリコピロレート錠市場規模予測（2018年-2029年）
- グリコピロレート錠の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- グリコピロレート錠市場の競争状況およびトレンド

・グリコピロレート錠の地域別市場規模
- 北米のグリコピロレート錠市場規模（2018年-2029年）
- 米国のグリコピロレート錠市場規模（2018年-2029年）
- ヨーロッパのグリコピロレート錠市場規模（2018年-2029年）
- アジア太平洋のグリコピロレート錠市場規模（2018年-2029年）
- 中国のグリコピロレート錠市場規模（2018年-2029年）
- 日本のグリコピロレート錠市場規模（2018年-2029年）
- 韓国のグリコピロレート錠市場規模（2018年-2029年）
- インドのグリコピロレート錠市場規模（2018年-2029年）
- オーストラリアのグリコピロレート錠市場規模（2018年-2029年）
- 中南米のグリコピロレート錠市場規模（2018年-2029年）
- 中東・アフリカのグリコピロレート錠市場規模（2018年-2029年）

・種類別セグメント：0.5mg、1mg、2mg
- 世界のグリコピロレート錠のタイプ別販売量（2018年-2023年）
- 世界のグリコピロレート錠のタイプ別売上（2018年-2023年）
- 世界のグリコピロレート錠のタイプ別価格

・用途別セグメント：病院、クリニック、その他
- 世界のグリコピロレート錠の用途別販売量（2018年-2023年）
- 世界のグリコピロレート錠の用途別売上（2018年-2023年）
- 世界のグリコピロレート錠の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Rising Pharmaceuticals、Kinedexe UK、Intas Pharmaceutical、Aurobindo Pharma USA、Edenbridge Pharmaceuticals、Heritage Pharmaceuticals、Ranbaxy Pharmaceuticals、Sciele Pharma、Boca Pharmacal、Solco Healthcare、Natco Pharma、Dr. Reddy’s Laboratories、Dongting Pharmaceutical、Alembic Labs、Leading Pharma、LGM Pharma Solutions、Nexgen Pharma、Par Pharmaceutical

・産業チェーンと販売チャネルの分析
- グリコピロレート錠産業チェーン分析
- グリコピロレート錠の主要原材料
- グリコピロレート錠の販売チャネル
- グリコピロレート錠のディストリビューター
- グリコピロレート錠の主要顧客

・グリコピロレート錠市場ダイナミクス
- グリコピロレート錠の業界動向
- グリコピロレート錠市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Glycopyrrolate Tablets market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Glycopyrrolate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Glycopyrrolate Tablets is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Glycopyrrolate Tablets include Rising Pharmaceuticals, Kinedexe UK, Intas Pharmaceutical, Aurobindo Pharma USA, Edenbridge Pharmaceuticals, Heritage Pharmaceuticals, Ranbaxy Pharmaceuticals, Sciele Pharma and Boca Pharmacal, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glycopyrrolate Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycopyrrolate Tablets.
The Glycopyrrolate Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Glycopyrrolate Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycopyrrolate Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Rising Pharmaceuticals
Kinedexe UK
Intas Pharmaceutical
Aurobindo Pharma USA
Edenbridge Pharmaceuticals
Heritage Pharmaceuticals
Ranbaxy Pharmaceuticals
Sciele Pharma
Boca Pharmacal
Solco Healthcare
Natco Pharma
Dr. Reddy’s Laboratories
Dongting Pharmaceutical
Alembic Labs
Leading Pharma
LGM Pharma Solutions
Nexgen Pharma
Par Pharmaceutical
Segment by Type
0.5mg
1mg
2mg
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycopyrrolate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glycopyrrolate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Glycopyrrolate Tablets Market Overview
1.1 Product Overview and Scope of Glycopyrrolate Tablets
1.2 Glycopyrrolate Tablets Segment by Type
1.2.1 Global Glycopyrrolate Tablets Market Value Comparison by Type (2023-2029)
1.2.2 0.5mg
1.2.3 1mg
1.2.4 2mg
1.3 Glycopyrrolate Tablets Segment by Application
1.3.1 Global Glycopyrrolate Tablets Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Glycopyrrolate Tablets Market Size Estimates and Forecasts
1.4.1 Global Glycopyrrolate Tablets Revenue 2018-2029
1.4.2 Global Glycopyrrolate Tablets Sales 2018-2029
1.4.3 Global Glycopyrrolate Tablets Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Glycopyrrolate Tablets Market Competition by Manufacturers
2.1 Global Glycopyrrolate Tablets Sales Market Share by Manufacturers (2018-2023)
2.2 Global Glycopyrrolate Tablets Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Glycopyrrolate Tablets Average Price by Manufacturers (2018-2023)
2.4 Global Glycopyrrolate Tablets Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Glycopyrrolate Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glycopyrrolate Tablets, Product Type & Application
2.7 Glycopyrrolate Tablets Market Competitive Situation and Trends
2.7.1 Glycopyrrolate Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glycopyrrolate Tablets Players Market Share by Revenue
2.7.3 Global Glycopyrrolate Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycopyrrolate Tablets Retrospective Market Scenario by Region
3.1 Global Glycopyrrolate Tablets Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Glycopyrrolate Tablets Global Glycopyrrolate Tablets Sales by Region: 2018-2029
3.2.1 Global Glycopyrrolate Tablets Sales by Region: 2018-2023
3.2.2 Global Glycopyrrolate Tablets Sales by Region: 2024-2029
3.3 Global Glycopyrrolate Tablets Global Glycopyrrolate Tablets Revenue by Region: 2018-2029
3.3.1 Global Glycopyrrolate Tablets Revenue by Region: 2018-2023
3.3.2 Global Glycopyrrolate Tablets Revenue by Region: 2024-2029
3.4 North America Glycopyrrolate Tablets Market Facts & Figures by Country
3.4.1 North America Glycopyrrolate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Glycopyrrolate Tablets Sales by Country (2018-2029)
3.4.3 North America Glycopyrrolate Tablets Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glycopyrrolate Tablets Market Facts & Figures by Country
3.5.1 Europe Glycopyrrolate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Glycopyrrolate Tablets Sales by Country (2018-2029)
3.5.3 Europe Glycopyrrolate Tablets Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glycopyrrolate Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Glycopyrrolate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Glycopyrrolate Tablets Sales by Country (2018-2029)
3.6.3 Asia Pacific Glycopyrrolate Tablets Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glycopyrrolate Tablets Market Facts & Figures by Country
3.7.1 Latin America Glycopyrrolate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Glycopyrrolate Tablets Sales by Country (2018-2029)
3.7.3 Latin America Glycopyrrolate Tablets Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glycopyrrolate Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Glycopyrrolate Tablets Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Glycopyrrolate Tablets Sales by Country (2018-2029)
3.8.3 Middle East and Africa Glycopyrrolate Tablets Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glycopyrrolate Tablets Sales by Type (2018-2029)
4.1.1 Global Glycopyrrolate Tablets Sales by Type (2018-2023)
4.1.2 Global Glycopyrrolate Tablets Sales by Type (2024-2029)
4.1.3 Global Glycopyrrolate Tablets Sales Market Share by Type (2018-2029)
4.2 Global Glycopyrrolate Tablets Revenue by Type (2018-2029)
4.2.1 Global Glycopyrrolate Tablets Revenue by Type (2018-2023)
4.2.2 Global Glycopyrrolate Tablets Revenue by Type (2024-2029)
4.2.3 Global Glycopyrrolate Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Glycopyrrolate Tablets Price by Type (2018-2029)
5 Segment by Application
5.1 Global Glycopyrrolate Tablets Sales by Application (2018-2029)
5.1.1 Global Glycopyrrolate Tablets Sales by Application (2018-2023)
5.1.2 Global Glycopyrrolate Tablets Sales by Application (2024-2029)
5.1.3 Global Glycopyrrolate Tablets Sales Market Share by Application (2018-2029)
5.2 Global Glycopyrrolate Tablets Revenue by Application (2018-2029)
5.2.1 Global Glycopyrrolate Tablets Revenue by Application (2018-2023)
5.2.2 Global Glycopyrrolate Tablets Revenue by Application (2024-2029)
5.2.3 Global Glycopyrrolate Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Glycopyrrolate Tablets Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Rising Pharmaceuticals
6.1.1 Rising Pharmaceuticals Corporation Information
6.1.2 Rising Pharmaceuticals Description and Business Overview
6.1.3 Rising Pharmaceuticals Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Rising Pharmaceuticals Glycopyrrolate Tablets Product Portfolio
6.1.5 Rising Pharmaceuticals Recent Developments/Updates
6.2 Kinedexe UK
6.2.1 Kinedexe UK Corporation Information
6.2.2 Kinedexe UK Description and Business Overview
6.2.3 Kinedexe UK Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Kinedexe UK Glycopyrrolate Tablets Product Portfolio
6.2.5 Kinedexe UK Recent Developments/Updates
6.3 Intas Pharmaceutical
6.3.1 Intas Pharmaceutical Corporation Information
6.3.2 Intas Pharmaceutical Description and Business Overview
6.3.3 Intas Pharmaceutical Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Intas Pharmaceutical Glycopyrrolate Tablets Product Portfolio
6.3.5 Intas Pharmaceutical Recent Developments/Updates
6.4 Aurobindo Pharma USA
6.4.1 Aurobindo Pharma USA Corporation Information
6.4.2 Aurobindo Pharma USA Description and Business Overview
6.4.3 Aurobindo Pharma USA Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Aurobindo Pharma USA Glycopyrrolate Tablets Product Portfolio
6.4.5 Aurobindo Pharma USA Recent Developments/Updates
6.5 Edenbridge Pharmaceuticals
6.5.1 Edenbridge Pharmaceuticals Corporation Information
6.5.2 Edenbridge Pharmaceuticals Description and Business Overview
6.5.3 Edenbridge Pharmaceuticals Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Edenbridge Pharmaceuticals Glycopyrrolate Tablets Product Portfolio
6.5.5 Edenbridge Pharmaceuticals Recent Developments/Updates
6.6 Heritage Pharmaceuticals
6.6.1 Heritage Pharmaceuticals Corporation Information
6.6.2 Heritage Pharmaceuticals Description and Business Overview
6.6.3 Heritage Pharmaceuticals Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Heritage Pharmaceuticals Glycopyrrolate Tablets Product Portfolio
6.6.5 Heritage Pharmaceuticals Recent Developments/Updates
6.7 Ranbaxy Pharmaceuticals
6.6.1 Ranbaxy Pharmaceuticals Corporation Information
6.6.2 Ranbaxy Pharmaceuticals Description and Business Overview
6.6.3 Ranbaxy Pharmaceuticals Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Ranbaxy Pharmaceuticals Glycopyrrolate Tablets Product Portfolio
6.7.5 Ranbaxy Pharmaceuticals Recent Developments/Updates
6.8 Sciele Pharma
6.8.1 Sciele Pharma Corporation Information
6.8.2 Sciele Pharma Description and Business Overview
6.8.3 Sciele Pharma Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sciele Pharma Glycopyrrolate Tablets Product Portfolio
6.8.5 Sciele Pharma Recent Developments/Updates
6.9 Boca Pharmacal
6.9.1 Boca Pharmacal Corporation Information
6.9.2 Boca Pharmacal Description and Business Overview
6.9.3 Boca Pharmacal Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Boca Pharmacal Glycopyrrolate Tablets Product Portfolio
6.9.5 Boca Pharmacal Recent Developments/Updates
6.10 Solco Healthcare
6.10.1 Solco Healthcare Corporation Information
6.10.2 Solco Healthcare Description and Business Overview
6.10.3 Solco Healthcare Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Solco Healthcare Glycopyrrolate Tablets Product Portfolio
6.10.5 Solco Healthcare Recent Developments/Updates
6.11 Natco Pharma
6.11.1 Natco Pharma Corporation Information
6.11.2 Natco Pharma Glycopyrrolate Tablets Description and Business Overview
6.11.3 Natco Pharma Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Natco Pharma Glycopyrrolate Tablets Product Portfolio
6.11.5 Natco Pharma Recent Developments/Updates
6.12 Dr. Reddy’s Laboratories
6.12.1 Dr. Reddy’s Laboratories Corporation Information
6.12.2 Dr. Reddy’s Laboratories Glycopyrrolate Tablets Description and Business Overview
6.12.3 Dr. Reddy’s Laboratories Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Dr. Reddy’s Laboratories Glycopyrrolate Tablets Product Portfolio
6.12.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.13 Dongting Pharmaceutical
6.13.1 Dongting Pharmaceutical Corporation Information
6.13.2 Dongting Pharmaceutical Glycopyrrolate Tablets Description and Business Overview
6.13.3 Dongting Pharmaceutical Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Dongting Pharmaceutical Glycopyrrolate Tablets Product Portfolio
6.13.5 Dongting Pharmaceutical Recent Developments/Updates
6.14 Alembic Labs
6.14.1 Alembic Labs Corporation Information
6.14.2 Alembic Labs Glycopyrrolate Tablets Description and Business Overview
6.14.3 Alembic Labs Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Alembic Labs Glycopyrrolate Tablets Product Portfolio
6.14.5 Alembic Labs Recent Developments/Updates
6.15 Leading Pharma
6.15.1 Leading Pharma Corporation Information
6.15.2 Leading Pharma Glycopyrrolate Tablets Description and Business Overview
6.15.3 Leading Pharma Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Leading Pharma Glycopyrrolate Tablets Product Portfolio
6.15.5 Leading Pharma Recent Developments/Updates
6.16 LGM Pharma Solutions
6.16.1 LGM Pharma Solutions Corporation Information
6.16.2 LGM Pharma Solutions Glycopyrrolate Tablets Description and Business Overview
6.16.3 LGM Pharma Solutions Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.16.4 LGM Pharma Solutions Glycopyrrolate Tablets Product Portfolio
6.16.5 LGM Pharma Solutions Recent Developments/Updates
6.17 Nexgen Pharma
6.17.1 Nexgen Pharma Corporation Information
6.17.2 Nexgen Pharma Glycopyrrolate Tablets Description and Business Overview
6.17.3 Nexgen Pharma Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Nexgen Pharma Glycopyrrolate Tablets Product Portfolio
6.17.5 Nexgen Pharma Recent Developments/Updates
6.18 Par Pharmaceutical
6.18.1 Par Pharmaceutical Corporation Information
6.18.2 Par Pharmaceutical Glycopyrrolate Tablets Description and Business Overview
6.18.3 Par Pharmaceutical Glycopyrrolate Tablets Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Par Pharmaceutical Glycopyrrolate Tablets Product Portfolio
6.18.5 Par Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glycopyrrolate Tablets Industry Chain Analysis
7.2 Glycopyrrolate Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glycopyrrolate Tablets Production Mode & Process
7.4 Glycopyrrolate Tablets Sales and Marketing
7.4.1 Glycopyrrolate Tablets Sales Channels
7.4.2 Glycopyrrolate Tablets Distributors
7.5 Glycopyrrolate Tablets Customers
8 Glycopyrrolate Tablets Market Dynamics
8.1 Glycopyrrolate Tablets Industry Trends
8.2 Glycopyrrolate Tablets Market Drivers
8.3 Glycopyrrolate Tablets Market Challenges
8.4 Glycopyrrolate Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Glycopyrrolate Tablets Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Glycopyrrolate Tablets Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Glycopyrrolate Tablets Market Competitive Situation by Manufacturers in 2022
Table 4. Global Glycopyrrolate Tablets Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Glycopyrrolate Tablets Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Glycopyrrolate Tablets Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Glycopyrrolate Tablets Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Glycopyrrolate Tablets Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Glycopyrrolate Tablets, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Glycopyrrolate Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glycopyrrolate Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Glycopyrrolate Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glycopyrrolate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycopyrrolate Tablets as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glycopyrrolate Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Glycopyrrolate Tablets Sales by Region (2018-2023) & (K Units)
Table 18. Global Glycopyrrolate Tablets Sales Market Share by Region (2018-2023)
Table 19. Global Glycopyrrolate Tablets Sales by Region (2024-2029) & (K Units)
Table 20. Global Glycopyrrolate Tablets Sales Market Share by Region (2024-2029)
Table 21. Global Glycopyrrolate Tablets Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Glycopyrrolate Tablets Revenue Market Share by Region (2018-2023)
Table 23. Global Glycopyrrolate Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Glycopyrrolate Tablets Revenue Market Share by Region (2024-2029)
Table 25. North America Glycopyrrolate Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Glycopyrrolate Tablets Sales by Country (2018-2023) & (K Units)
Table 27. North America Glycopyrrolate Tablets Sales by Country (2024-2029) & (K Units)
Table 28. North America Glycopyrrolate Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Glycopyrrolate Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Glycopyrrolate Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Glycopyrrolate Tablets Sales by Country (2018-2023) & (K Units)
Table 32. Europe Glycopyrrolate Tablets Sales by Country (2024-2029) & (K Units)
Table 33. Europe Glycopyrrolate Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Glycopyrrolate Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Glycopyrrolate Tablets Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Glycopyrrolate Tablets Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Glycopyrrolate Tablets Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Glycopyrrolate Tablets Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Glycopyrrolate Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Glycopyrrolate Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Glycopyrrolate Tablets Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Glycopyrrolate Tablets Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Glycopyrrolate Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Glycopyrrolate Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Glycopyrrolate Tablets Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Glycopyrrolate Tablets Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Glycopyrrolate Tablets Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Glycopyrrolate Tablets Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Glycopyrrolate Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Glycopyrrolate Tablets Sales (K Units) by Type (2018-2023)
Table 51. Global Glycopyrrolate Tablets Sales (K Units) by Type (2024-2029)
Table 52. Global Glycopyrrolate Tablets Sales Market Share by Type (2018-2023)
Table 53. Global Glycopyrrolate Tablets Sales Market Share by Type (2024-2029)
Table 54. Global Glycopyrrolate Tablets Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Glycopyrrolate Tablets Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Glycopyrrolate Tablets Revenue Market Share by Type (2018-2023)
Table 57. Global Glycopyrrolate Tablets Revenue Market Share by Type (2024-2029)
Table 58. Global Glycopyrrolate Tablets Price (US$/Unit) by Type (2018-2023)
Table 59. Global Glycopyrrolate Tablets Price (US$/Unit) by Type (2024-2029)
Table 60. Global Glycopyrrolate Tablets Sales (K Units) by Application (2018-2023)
Table 61. Global Glycopyrrolate Tablets Sales (K Units) by Application (2024-2029)
Table 62. Global Glycopyrrolate Tablets Sales Market Share by Application (2018-2023)
Table 63. Global Glycopyrrolate Tablets Sales Market Share by Application (2024-2029)
Table 64. Global Glycopyrrolate Tablets Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Glycopyrrolate Tablets Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Glycopyrrolate Tablets Revenue Market Share by Application (2018-2023)
Table 67. Global Glycopyrrolate Tablets Revenue Market Share by Application (2024-2029)
Table 68. Global Glycopyrrolate Tablets Price (US$/Unit) by Application (2018-2023)
Table 69. Global Glycopyrrolate Tablets Price (US$/Unit) by Application (2024-2029)
Table 70. Rising Pharmaceuticals Corporation Information
Table 71. Rising Pharmaceuticals Description and Business Overview
Table 72. Rising Pharmaceuticals Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Rising Pharmaceuticals Glycopyrrolate Tablets Product
Table 74. Rising Pharmaceuticals Recent Developments/Updates
Table 75. Kinedexe UK Corporation Information
Table 76. Kinedexe UK Description and Business Overview
Table 77. Kinedexe UK Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Kinedexe UK Glycopyrrolate Tablets Product
Table 79. Kinedexe UK Recent Developments/Updates
Table 80. Intas Pharmaceutical Corporation Information
Table 81. Intas Pharmaceutical Description and Business Overview
Table 82. Intas Pharmaceutical Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Intas Pharmaceutical Glycopyrrolate Tablets Product
Table 84. Intas Pharmaceutical Recent Developments/Updates
Table 85. Aurobindo Pharma USA Corporation Information
Table 86. Aurobindo Pharma USA Description and Business Overview
Table 87. Aurobindo Pharma USA Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Aurobindo Pharma USA Glycopyrrolate Tablets Product
Table 89. Aurobindo Pharma USA Recent Developments/Updates
Table 90. Edenbridge Pharmaceuticals Corporation Information
Table 91. Edenbridge Pharmaceuticals Description and Business Overview
Table 92. Edenbridge Pharmaceuticals Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Edenbridge Pharmaceuticals Glycopyrrolate Tablets Product
Table 94. Edenbridge Pharmaceuticals Recent Developments/Updates
Table 95. Heritage Pharmaceuticals Corporation Information
Table 96. Heritage Pharmaceuticals Description and Business Overview
Table 97. Heritage Pharmaceuticals Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Heritage Pharmaceuticals Glycopyrrolate Tablets Product
Table 99. Heritage Pharmaceuticals Recent Developments/Updates
Table 100. Ranbaxy Pharmaceuticals Corporation Information
Table 101. Ranbaxy Pharmaceuticals Description and Business Overview
Table 102. Ranbaxy Pharmaceuticals Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Ranbaxy Pharmaceuticals Glycopyrrolate Tablets Product
Table 104. Ranbaxy Pharmaceuticals Recent Developments/Updates
Table 105. Sciele Pharma Corporation Information
Table 106. Sciele Pharma Description and Business Overview
Table 107. Sciele Pharma Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Sciele Pharma Glycopyrrolate Tablets Product
Table 109. Sciele Pharma Recent Developments/Updates
Table 110. Boca Pharmacal Corporation Information
Table 111. Boca Pharmacal Description and Business Overview
Table 112. Boca Pharmacal Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Boca Pharmacal Glycopyrrolate Tablets Product
Table 114. Boca Pharmacal Recent Developments/Updates
Table 115. Solco Healthcare Corporation Information
Table 116. Solco Healthcare Description and Business Overview
Table 117. Solco Healthcare Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Solco Healthcare Glycopyrrolate Tablets Product
Table 119. Solco Healthcare Recent Developments/Updates
Table 120. Natco Pharma Corporation Information
Table 121. Natco Pharma Description and Business Overview
Table 122. Natco Pharma Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Natco Pharma Glycopyrrolate Tablets Product
Table 124. Natco Pharma Recent Developments/Updates
Table 125. Dr. Reddy’s Laboratories Corporation Information
Table 126. Dr. Reddy’s Laboratories Description and Business Overview
Table 127. Dr. Reddy’s Laboratories Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Dr. Reddy’s Laboratories Glycopyrrolate Tablets Product
Table 129. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 130. Dongting Pharmaceutical Corporation Information
Table 131. Dongting Pharmaceutical Description and Business Overview
Table 132. Dongting Pharmaceutical Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Dongting Pharmaceutical Glycopyrrolate Tablets Product
Table 134. Dongting Pharmaceutical Recent Developments/Updates
Table 135. Alembic Labs Corporation Information
Table 136. Alembic Labs Description and Business Overview
Table 137. Alembic Labs Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Alembic Labs Glycopyrrolate Tablets Product
Table 139. Alembic Labs Recent Developments/Updates
Table 140. Leading Pharma Corporation Information
Table 141. Leading Pharma Description and Business Overview
Table 142. Leading Pharma Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Leading Pharma Glycopyrrolate Tablets Product
Table 144. Leading Pharma Recent Developments/Updates
Table 145. LGM Pharma Solutions Corporation Information
Table 146. LGM Pharma Solutions Description and Business Overview
Table 147. LGM Pharma Solutions Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. LGM Pharma Solutions Glycopyrrolate Tablets Product
Table 149. LGM Pharma Solutions Recent Developments/Updates
Table 150. Nexgen Pharma Corporation Information
Table 151. Nexgen Pharma Description and Business Overview
Table 152. Nexgen Pharma Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Nexgen Pharma Glycopyrrolate Tablets Product
Table 154. Nexgen Pharma Recent Developments/Updates
Table 155. Par Pharmaceutical Corporation Information
Table 156. Par Pharmaceutical Description and Business Overview
Table 157. Par Pharmaceutical Glycopyrrolate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Par Pharmaceutical Glycopyrrolate Tablets Product
Table 159. Par Pharmaceutical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Glycopyrrolate Tablets Distributors List
Table 163. Glycopyrrolate Tablets Customers List
Table 164. Glycopyrrolate Tablets Market Trends
Table 165. Glycopyrrolate Tablets Market Drivers
Table 166. Glycopyrrolate Tablets Market Challenges
Table 167. Glycopyrrolate Tablets Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glycopyrrolate Tablets
Figure 2. Global Glycopyrrolate Tablets Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Glycopyrrolate Tablets Market Share by Type in 2022 & 2029
Figure 4. 0.5mg Product Picture
Figure 5. 1mg Product Picture
Figure 6. 2mg Product Picture
Figure 7. Global Glycopyrrolate Tablets Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Glycopyrrolate Tablets Market Share by Application in 2022 & 2029
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Global Glycopyrrolate Tablets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Glycopyrrolate Tablets Market Size (2018-2029) & (US$ Million)
Figure 14. Global Glycopyrrolate Tablets Sales (2018-2029) & (K Units)
Figure 15. Global Glycopyrrolate Tablets Average Price (US$/Unit) & (2018-2029)
Figure 16. Glycopyrrolate Tablets Report Years Considered
Figure 17. Glycopyrrolate Tablets Sales Share by Manufacturers in 2022
Figure 18. Global Glycopyrrolate Tablets Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Glycopyrrolate Tablets Players: Market Share by Revenue in 2022
Figure 20. Glycopyrrolate Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Glycopyrrolate Tablets Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Glycopyrrolate Tablets Sales Market Share by Country (2018-2029)
Figure 23. North America Glycopyrrolate Tablets Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Glycopyrrolate Tablets Sales Market Share by Country (2018-2029)
Figure 27. Europe Glycopyrrolate Tablets Revenue Market Share by Country (2018-2029)
Figure 28. Germany Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Glycopyrrolate Tablets Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Glycopyrrolate Tablets Revenue Market Share by Region (2018-2029)
Figure 35. China Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Glycopyrrolate Tablets Sales Market Share by Country (2018-2029)
Figure 46. Latin America Glycopyrrolate Tablets Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Glycopyrrolate Tablets Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Glycopyrrolate Tablets Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Glycopyrrolate Tablets Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Glycopyrrolate Tablets by Type (2018-2029)
Figure 56. Global Revenue Market Share of Glycopyrrolate Tablets by Type (2018-2029)
Figure 57. Global Glycopyrrolate Tablets Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Glycopyrrolate Tablets by Application (2018-2029)
Figure 59. Global Revenue Market Share of Glycopyrrolate Tablets by Application (2018-2029)
Figure 60. Global Glycopyrrolate Tablets Price (US$/Unit) by Application (2018-2029)
Figure 61. Glycopyrrolate Tablets Value Chain
Figure 62. Glycopyrrolate Tablets Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • メトトレキサート錠の世界市場2023年：2mg、2.5mg、10mg、その他
  • カプトプリル錠の世界市場2023年：25mg、12.5mg
  • 凍結乾燥口腔内崩壊錠のグローバル市場展望 2023年-2029年：医療用医薬品、一般用医薬品
  • アデノシン二ナトリウム三リン酸錠の世界市場2023年：20mg*12錠、20mg*24錠
  • アセチルシステイン注射の世界市場2023年：4g/20ml、6g/30ml
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8777 )"グリコピロレート錠の世界市場2023年：0.5mg、1mg、2mg" (英文：Global Glycopyrrolate Tablets Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。